MARK P COLONNESE Insider Trading Transactions
Get free email notifications about insider trading for MARK P COLONNESE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK P COLONNESE. MARK P COLONNESE is CFO and EVP in Aviragen Therapeutics, Inc. ($NABI) and Chief Financial Officer in Aviragen Therapeutics, Inc. ($NABI) and Exec VP Comm Operations & CFO in ATHEROGENICS INC ($AGIX) and Exec VP Commercial Operations in ATHEROGENICS INC ($AGIX) and Exec VP, Commercial Operations in ATHEROGENICS INC ($AGIX) and Sr VP Finance & Admin & CFO in ATHEROGENICS INC ($AGIX) and Sr VP Finance & Admin, CFO in ATHEROGENICS INC ($AGIX) and Sr VP Finance, Admin & CFO in ATHEROGENICS INC ($AGIX) and Sr VP Finance/Admin & CFO in ATHEROGENICS INC ($AGIX) and Sr VP, Finance & Admin, CFO in ATHEROGENICS INC ($AGIX) and Director in BIO-PATH HOLDINGS INC ($BPTH).
Latest Insider Trading Transactions of MARK P COLONNESE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIX, BPTH, VXRT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2019 | BPTH | BIO-PATH HOLDINGS ... | COLONNESE MARK P | Director | Option Exercise | A | 18.40 | 1,000 | 18,400 | 1,000 | |
| Apr 01 2019 | BPTH | BIO-PATH HOLDINGS ... | COLONNESE MARK P | Director | Option Exercise | A | 18.40 | 1,000 | 18,400 | 1,000 | |
| Apr 19 2018 | BPTH | BIO-PATH HOLDINGS ... | COLONNESE MARK P | Director | Option Exercise | A | 1.68 | 20,000 | 33,500 | 20,000 | |
| Jul 17 2017 | BPTH | BIO-PATH HOLDINGS ... | COLONNESE MARK P | Director | Option Exercise | A | 0.38 | 25,000 | 9,500 | 25,000 | |
| Apr 05 2017 | AVIR | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Option Exercise | A | 0.66 | 400,000 | 262,400 | 775,000 | |
| Jul 29 2016 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | CFO and EVP | Option Exercise | A | 1.34 | 150,000 | 201,000 | 375,000 | |
| Feb 09 2016 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Buy | P | 1.41 | 6,700 | 9,428 | 7,000 | 300 to 7 K (+2,233.33 %) |
| Feb 09 2016 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Buy | P | 1.40 | 300 | 419 | 300 | 0 to 300 |
| Nov 03 2015 | NABI | Aviragen Therapeut ... | COLONNESE MARK P | Chief Financial Off ... | Option Exercise | A | 2.02 | 225,000 | 454,500 | 225,000 | |
| Jan 14 2008 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Exec VP Comm Operat ... | Option Exercise | A | 0.38 | 72,000 | 27,360 | 72,000 | |
| Jun 21 2007 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Exec VP Commercial ... | Option Exercise | A | 2.41 | 65,728 | 158,404 | 65,728 | |
| Mar 21 2007 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Exec VP, Commercial ... | Option Exercise | M | 0.38 | 25,000 | 9,500 | 70,600 | |
| Mar 21 2007 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Exec VP, Commercial ... | Buy | M | 0.38 | 25,000 | 9,500 | 25,000 | 0 to 25 K |
| Jan 04 2007 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Exec VP, Commercial ... | Option Exercise | A | 9.91 | 72,000 | 713,520 | 72,000 | |
| Jun 16 2006 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Exec VP, Commercial ... | Option Exercise | A | 13.29 | 12,000 | 159,480 | 12,000 | |
| Feb 23 2006 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance, Admi ... | Option Exercise | A | 15.78 | 60,000 | 946,800 | 60,000 | |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Option Exercise | M | 0.38 | 29,400 | 11,172 | 95,600 | |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Option Exercise | M | 0.31 | 20,000 | 6,200 | 0 | |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Option Exercise | M | 0.30 | 50,600 | 15,180 | 0 | |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Sell | S | 21.35 | 29,400 | 627,690 | 0 | 29.4 K to 0 (-100.00 %) |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Buy | M | 0.38 | 29,400 | 11,172 | 29,400 | 0 to 29.4 K |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Sell | S | 21.35 | 20,000 | 427,000 | 0 | 20 K to 0 (-100.00 %) |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Buy | M | 0.31 | 20,000 | 6,200 | 20,000 | 0 to 20 K |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Sell | S | 21.35 | 50,600 | 1,080,310 | 0 | 50.6 K to 0 (-100.00 %) |
| Dec 29 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Buy | M | 0.30 | 50,600 | 15,180 | 50,600 | 0 to 50.6 K |
| Feb 28 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance/Admin ... | Sell | S | 17.51 | 39,400 | 689,894 | 0 | 39.4 K to 0 (-100.00 %) |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Option Exercise | A | 14.86 | 57,000 | 847,020 | 57,000 | |
| Nov 19 2003 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP, Finance & Ad ... | Sell | S | 15.16 | 30,000 | 454,800 | 39,400 | 69.4 K to 39.4 K (-43.23 %) |
Page: 1